← Back to all trials
Terminated
NCT05313776
Identification of Non-motor Brain Areas Involved in Upper Limb Motor Recovery After Stroke
Conditions: Upper Limb Ischemia, Stroke
Sex: All
Ages: 18 Years – 85 Years
Healthy volunteers: Yes
Enrollment: 28
Sponsor: University Hospital, Montpellier
Location: Montpellier University Hospital Montpellier
Summary
Why: Upper-limb recovery post-stroke is challenging. Rehabilitation, aiming to induce plasticity takes an important place in patients' treatment. The last years, non-invasive brain stimulation of the primary motor cortex has gained the communities' interest, allowing direct modification of neural excitability and thus impacting plasticity. Yet, research outcomes remain inconclusive to date. It's expected this to be related to patient heterogeneity including mild to severe motor deficits, and suboptimal site of stimulation. It might be questioned whether M1 stimulation is preferable over that of higher association areas like the parietal or premotor cortex.
What: The aim of the study is to identify alternative brain regions to stimulate, related to improved motor quality after a severe initial deficit. How: by following motor recovery over time, by co-recording movement kinematics and brain activity.
Because: Stimulation of the novel identified regions may improve motor recovery after stroke.
Eligibility Criteria
Inclusion Criteria patients post-stroke:
* 18-85 yrs,
* First ever ischemic stroke of the middle cerebral artery,
* Initial severe motor deficit (fugl-Upper limb assessment score \3/5 on the Boston scale,
* Bilateral stroke,
* Hemorraghic stroke,
* MRI contra-indications,
* Pregnancy/breastfeading,
* Patient under curatele,
* Medical urgency.
Inclusion criteria healthy subjects:
* Age matching (+/- 5 yrs),
* Sexe matching,
* Written consent.
Exclusion criteria healthy subjets:
* Neurological or psychological deficits;
* MRI contra-indations;
* Pregnancy/breastfeeding,
* Personunder curatele.
Source: ClinicalTrials.gov (NCT05313776). StuddyBuddy aggregates publicly available trial information.